Parangliomas of the head and neck region, also known as glomus tumours or chemodectomas, arise from paraganglionic tissue at the carotid bifurcation and in the jugular fossa, the middle ear and the superior mediastinum. Together with the aortico-sympathetic, visceral-autonomic and intravagal paragangliomas and adrenal pheochromocytomas they form a class of tumours known as paragangliomas (Glenner & Grimley, 1974) . At least 30% of glomus tumours are familial in origin. Multiple tumours occur in approximately 25 to 35% of patients with familial disease but in less than 5% of those with the non-familial type (Grufferman et al., 1980) . Several authors have found the hereditary pattern of familial glomus tumours to be autosomal dominant (Grufferman et al., 1980; Parkin, 1981) . Recently, however, during a retrospective analysis of medical records from 15 affected pedigrees, our group found that the clinical manifestation of the disease is determined by the sex of the transmitting parent (van der Mey et al., 1989) . Children of female gene carriers never showed tumour growth, while the prevalence in offspring of male gene carriers increased with age to the expected 50% for an autosomal dominant disorder. This finding can be explained by genomic imprinting, i.e. the maternally derived gene is inactivated during o6genesis and can only be reactivated during spermatogenesis. For several disorders including Huntington's disease and myotonic dystrophy, this new concept has been suggested as a possible explanation for differences in clinical presentation, age of onset and severity that seem to be related to the parental origin of the disease gene. Its suggested role in carcinogenesis is supported by the finding that deletions or losses of chromosome 11 that occur in sporadic cases of Wilms tumour almost always involve the chromosome of maternal origin (Hall, 1990) . Paragangliomas are potentially capable of catecholamine production. The proportion of catecholamine secreting paragangliomas is thought to be high for adrenal pheochromocytomas, intermediate for aortico-sympathetic and visceral-autonomic paragangliomas and low for paragangliomas of the head and neck region (Dunn et al., 1986) . We previously reported that the prevalence of hormonally active glomus tumours and their association with other paragangliomas in non-familial cases might be well higher than has been previously suspected (van Gils et al., 1990 20-30, 30-40, 40-50 , and over 50 years of age) with penetrances of 10%, 35%, 65%, 90% and 95% respectively.
Likelihoods were calculated using version 5.03 of the Linkage package of computer programs (Lathrop & Lalouel, 1984) , with the frequency of the gene fixed at 0.0001. For the likelihood calculations under genomic imprinting the penetrance in children of female gene carriers was assumed to be 0.0, irrespective of age.
Results
One member (V-25) underwent clinical examination but did not have an MRI examination because of claustrophobia. In this patient computed tomography of the head and neck was performed instead. Individual IV-15, who is an obligate carrier and may well have the disease subclinically, and three of his five children who are at high risk of being affected, refused MR or CT screening despite several requests. All other participants completed the study. Table I lists the clinical, hormonal and MR findings of the affected family members with one or more tumours. Examination of medical records revealed two deceased members (III-3, IV-18) in whom glomus tumours had been diagnosed by means of angiography and surgery. In the family member IV-4 who died from amyotrophic lateral sclerosis, no evidence of glomus tumours had been found on previously performed contrast enhanced CT examinations. The past medical and familial history of relatives II-1, 11-2, III-1, III-2 and IV-5 was not suggestive of the presence of paragangliomas.
Glomus tumours
Clinical examination of the eight previously diagnosed glomus tumour patients revealed no new tumours. Among their relatives one (IV-10) complained of unsteadiness which she attributed to old age, but no tumours were found on physical examination. In another relative (IV-20) who also suffered from neurofibromatosis, bilateral carotid masses were felt in the neck.
In the eight known patients, the MR examinations of the head and neck demonstrated all previously diagnosed tumours and in addition, two hitherto unrecognised glomus tumours in two of the subjects (IV-17, V-13). In 6 undiagnosed relatives (IV-10, IV-13, IV-20, IV-22, V-64, V-66) 10 chemodectomas were found on MRI. In total MRI demonstrated 20 glomus tumours comprising eight carotid body tumours, three vagal body tumours and nine jugulotympanic tumours. Of the 14 living patients seven had multicentric lesions (50%). Tumour diameter ranged from 5 mm to 70 mm. A small vagal body tumour and a carotid body tumour were not visible on CT, but were confirmed by angiography.
In the patient with neurofibromatosis on MRI subcutaneous neurofibromas and a large skull lesion were found. The latter proved to be a so-called 'lambdoid defect' on skull roentgenograms (Resnick, 1989) . Furthermore, in one relative, MRI showed a small cerebellar vascular malformation that was considered to be a coincidental finding.
Functioning paragangliomas All participants underwent the urinary screening tests. Only one of the known patients (V-19) had a history that was indicative of a functioning paraganglioma, i.e. hypertension, episodic headaches, palpitations and heavy perspiration. This patient and two of the relatives (V-12, V-64) were found to have elevated urinary excretion of catecholamihes. In two subjects (V-19, V-64) MRI and MIBG scintigraphy re- The new cases of glomus tumour that were detected in this study occurred only in persons that had inherited the disease gene from their father. Our new findings are completely consistent with predictions based on the genomic imprinting theory, i.e. the gene is transmitted by both men and women, but only leads to disease manifestations when inherited via the father. Given a complete autosomal dominant transmission by males, the three affected females should have had seven or eight affected children, but they had none. These observations are summarised in our statistical evaluation, which provides convincing odds supporting the genomic imprinting hypothesis.
On the basis of this theory and the high percentage of asymptomatic patients found in our study, it can even be speculated that a proportion of ostensibly sporadic glomus tumours are in fact familial tumours that have been transmitted over several generations by the maternal line or by male patients with undetected tumours. A more accurate assessment of the proportion of isolated cases can only be obtained when the genetic defect has been characterised.
We dealt with a familial tumour syndrome. The common characteristics of the familial tumours are increased risk to the families of the patients, lower age of onset and multiplicity of tumours. The average age of tumour diagnosis in non-familial patients is 42.5 years, compared with a mean age at diagnosis of 38.8 years in our group (Grufferman et al., 1980) . In the fifth generation, in part due to our screening efforts, tumours were even diagnosed at a much earlier age (Table I ). The more advanced age for tumour diagnosis in non-familial patients is probably due to the lack of suspicion and the initial absence of symptoms. Even in our group with highly aware individuals some affected members had reached an advanced age without any disturbing symptoms.
In the living patients, multiplicity (50%) and hormonal activity (21%) was diagnosed in a considerably higher frequency than has been reported in the past (Grufferman et 13 1935 1920 1922 1923 1927 1928 1930 1928 1929 1933 1936 1943 1946 1948 (van Gils et al., 1991) . Moreover, MRI can detect chemodectomas smaller than 5 mm, while contrast enhanced CT only allows detection of tumours greater than 8 mm (Vogl et al., 1989 (Grimley, 1989 (van Gils et al., 1990) . This paucity of symptoms and the presence of only minimal biochemical abnormalities bears a striking resemblance to the behaviour of pheochromocytomas in MEN II (Stein & Black, 1991) .
In the case of multiple paragangliomas and elevated catecholamine levels, such as our cases V-19, and V-64, one is not certain which tumour is active. In these cases MIBG scintigraphy is invaluable to localise the functioning lesion that has to be removed first (van Gils et al., 1990) . One patient showed cutaneous neurofibromas and a lambda defect in the skull together with two carotid body tumours. The association of neurofibromatosis with adrenal pheochromocytomas is well known but the combination of neurofibromatosis and multicentric extra-adrenal paragangliomas has only been reported once in English literature (DeAngelis et al., 1987) . A third case was found in German literature (Loblich & Baumann, 1960) . Although rare this combination constitutes further evidence for Bolande's theory that both disorders are neurocristopathies (Bolande, 1974) .
In conclusion, by means of prospective screening with MRI, this study provides further evidence for the theory that inheritance of familial paragangliomas is subject to genomic imprinting. When a paraganglioma is detected an extensive search should be performed for additional tumours and familial occurrence should be considered. For this purpose, screening with MRI is the method of choice, not only because it has no adverse side-effects, but also because of its very high sensitivity. In keeping with our results in another non-familial patient group hormonal activity was not an infrequent finding in this patient group. Because symptoms and signs are usually minimal, periodic examination of indi-834
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.1-viduals at risk will allow the detection of tumours and hormonal activity in a presymptomatic and still localised stage. This in turn allows therapeutic intervention at an early stage thus providing a basis for secondary prevention.
